childhood nodular sclerosis Hodgkin lymphoma
Showing 1 - 25 of >10,000
Childhood Favorable Prognosis Hodgkin Lymphoma, Childhood Lymphocyte Depletion Hodgkin Lymphoma, Childhood Mixed Cellularity
Completed
- Childhood Favorable Prognosis Hodgkin Lymphoma
- +5 more
- radiation therapy
- +11 more
-
Arcadia, CaliforniaChildren's Oncology Group
Mar 26, 2021
Quality of Life in Adult and Pediatric Nodular
Recruiting
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma
-
Aurora, Colorado
- +1 more
Oct 27, 2023
Nodular Lymphocyte Predominant Hodgkin Lymphoma, Recurrent Nodular Lymphocyte Predominant Hodgkin Lymphoma, Refractory Nodular
Not yet recruiting
- Nodular Lymphocyte Predominant Hodgkin Lymphoma
- +2 more
- Biopsy
- +9 more
- (no location specified)
Jun 1, 2023
Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin
Completed
- Adult Lymphocyte Depletion Hodgkin Lymphoma
- +5 more
- gemcitabine hydrochloride
- bendamustine hydrochloride
-
Atlanta, Georgia
- +1 more
Oct 21, 2021
Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin
Active, not recruiting
- Adult Lymphocyte Depletion Hodgkin Lymphoma
- +16 more
- 6,8-bis(benzylthio)octanoic acid
- bendamustine hydrochloride
-
Winston-Salem, North Carolina
- +1 more
Apr 8, 2022
Acute Lymphoblastic Leukemia, Hodgkin Disease, Allogeneic Stem Cell Transplantation Trial in Erlangen (Low-field magnetic
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- Low-field magnetic resonance imaging
- +3 more
-
Erlangen, Bavaria, GermanyDepartment of Pediatrics and Adolescent Medicine
Oct 23, 2023
Childhood Non-Hodgkin Lymphoma, Childhood Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia Trial in Oslo,
Recruiting
- Childhood Non-Hodgkin Lymphoma
- +2 more
- Goal Management Training (GMT)
- Brain Health Workshop (BHW)
-
Oslo, Norway
- +2 more
May 25, 2022
Frailty in Young Adult Survivors of Childhood Cancer
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +2 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 8, 2022
Nodular Lymphocyte-Predominant Hodgkin's Lymphoma Trial in Cologne (Ibrutinib)
Completed
- Nodular Lymphocyte-Predominant Hodgkin's Lymphoma
-
Cologne, Germany1st Department of Medicine, Cologne University Hospital
Apr 6, 2021
Lymphoma Trial in Giessen (drug, other, procedure)
Active, not recruiting
- Lymphoma
- cyclophosphamide
- +4 more
-
Giessen, GermanyUniversitaetsklinikum Giessen-Marburg
May 10, 2021
ADLs at End of Acute Treatment for Childhood Leukemia and
Enrolling by invitation
- Childhood Cancer
- Assessment of the accomplishment regarding Activities of Daily Living at the end of acute treatment
-
Munich, GermanyKinderklinik München Schwabing, TUM School of Medicine, Departme
May 9, 2022
Cognitive Impairment in Young Patients With Cancer Prospectively
Recruiting
- Chemotherapy-Related Cognitive Impairment
- +9 more
-
Copenhagen, DenmarkRigshospitalet
Apr 24, 2023
Ann Arbor Stage I Hodgkin Lymphoma, Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma, Ann Arbor Stage I Nodular
Recruiting
- Ann Arbor Stage I Hodgkin Lymphoma
- +13 more
- Bleomycin
- +6 more
-
Birmingham, Alabama
- +16 more
Nov 23, 2021
ALL, Hodgkin Lymphoma, Cancer Trial in Memphis (Transcranial photobiomodulation (tPBM) - Mobile System)
Not yet recruiting
- ALL
- +3 more
- Transcranial photobiomodulation (tPBM) - Mobile System
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Dec 6, 2022
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Recruiting
- Recurrent Childhood Acute Myeloid Leukemia
- +17 more
-
Miami, FloridaNicklaus Children's Hospital
May 13, 2023
Ex Vivo Drug Sensitivity Testing and Mutation Profiling
Completed
- Recurrent Childhood Acute Myeloid Leukemia
- +13 more
-
Miami, FloridaNicklaus Children's Hospital
Jan 18, 2023
Familial Investigations of Childhood Cancer Predisposition
Recruiting
- Acute Leukemia
- +45 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
May 11, 2022
Immune Responses to COVID-19 Vaccination in Lymphoma Patients
Active, not recruiting
- Classical Hodgkin Lymphoma
- +12 more
-
Bedford, Bedfordshire, United Kingdom
- +8 more
Feb 22, 2022
Lymphoma, Childhood Lymphoma, Solid Tumor Trial in Charlottesville (Genistein, Placebo)
Terminated
- Lymphoma
- +15 more
- Genistein
- Placebo
-
Charlottesville, VirginiaUniversity of Virginia
Feb 8, 2022
Pediatric Cancer, Hodgkin Disease, CD30-Positive DLBCL Trial in Milwaukee (anti-CD30 Bispecific Antibody-armed
Not yet recruiting
- Pediatric Cancer
- +11 more
- anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)
-
Milwaukee, WisconsinChildren's Wisconsin
Sep 14, 2022
Childhood Cancer Trial in Munich (Exercise)
Completed
- Childhood Cancer
- Exercise
-
Munich, Bavaria, GermanyKinderklinik München Schwabing TUM School of Medicine, Departmen
May 26, 2021
T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail
Recruiting
- T-cell Lymphoma
- +30 more
- Optional Blood Sample
- Optional Nail Sample
-
Duarte, California
- +25 more
Jul 28, 2023
Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +35 more
-
Birmingham, Alabama
- +113 more
Jun 28, 2022
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia
- +125 more
- tetanus-CMV fusion peptide vaccine
- laboratory biomarker analysis
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022